c-Myc tag Peptide: Precision Reagent for Immunoassays & Cancer Research

Executive Summary: The c-Myc tag Peptide (SKU: A6003) is a synthetic peptide that mimics amino acids 410–419 of human c-Myc, enabling competitive displacement of c-Myc-tagged fusion proteins from anti-c-Myc antibodies in immunoassays (APExBIO). Its use underpins studies of c-Myc, a transcription factor central to cell proliferation, apoptosis, and oncogenesis (Wu et al. 2021). The peptide is soluble up to 60.17 mg/mL in DMSO and 15.7 mg/mL in water with ultrasonic treatment, but insoluble in ethanol. It is intended for research use only and should not be used in human diagnostics or therapy. This article benchmarks the product's utility, clarifies its mechanistic rationale, and provides workflow integration guidance based on peer-reviewed and manufacturer data.

Biological Rationale

c-Myc is a proto-oncogene encoding a transcription factor involved in cell cycle regulation, growth, differentiation, and apoptosis (Wu et al. 2021). Aberrant c-Myc activity is linked to unregulated proliferation and multiple cancers. The c-Myc tag is a widely used epitope (EQKLISEEDL) for labeling fusion proteins, facilitating their detection and purification via anti-c-Myc antibodies. Synthetic c-Myc peptides enable competitive displacement in immunoassays, allowing precise control over protein-antibody interactions (APExBIO).

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide (amino acids 410–419 of human c-Myc) binds specifically to anti-c-Myc monoclonal antibodies, competitively inhibiting antibody interaction with c-Myc-tagged proteins in solution or immobilized on solid phases. This displacement mechanism is exploited in immunoprecipitation and western blot elution protocols (related article). Unlike full-length c-Myc, the synthetic peptide lacks transcriptional activity, serving solely as a competitive epitope mimic. Its high solubility in DMSO (≥60.17 mg/mL) and in water with sonication (≥15.7 mg/mL) ensures utility across diverse assay formats (APExBIO).

Evidence & Benchmarks

• c-Myc tag Peptide can displace c-Myc-tagged proteins from anti-c-Myc antibody complexes in immunoassays, enabling specific elution and reducing background (APExBIO).
• The c-Myc peptide sequence (EQKLISEEDL) is empirically validated for high-affinity binding to the 9E10 monoclonal antibody in multiple assay platforms (Wu et al. 2021).
• c-Myc is a master regulator of cell proliferation, apoptosis, and differentiation, and its overexpression is associated with aggressive tumorigenesis (Wu et al. 2021).
• The peptide remains stable when stored desiccated at –20°C and is not recommended for long-term solution storage to avoid degradation (APExBIO).
• Recent mechanistic studies link transcription factor regulation (c-Myc, IRF3) with autophagy and immune modulation, contextualizing the peptide's research relevance (Wu et al. 2021).

Applications, Limits & Misconceptions

The c-Myc tag Peptide is used for:

• Displacement of c-Myc-tagged fusion proteins in immunoprecipitation and affinity purification workflows.
• Competitive inhibition in ELISA or western blot detection using anti-c-Myc antibodies.
• Control experiments to validate antibody specificity.
• Research into transcription factor regulation and proto-oncogene function, especially in cancer models (related article; this article provides updated benchmarks and precise solubility data compared to earlier guidance).

For advanced discussion of mechanistic intersections with autophagy and immune regulation, see this resource; here we extend with new evidence on peptide stability and workflow integration.

Common Pitfalls or Misconceptions

• Not for in vivo use: The peptide is for research use only and not approved for diagnostic or therapeutic applications.
• Ethanol solubility: The peptide is insoluble in ethanol and will precipitate; use DMSO or water with ultrasonic treatment for dissolution (APExBIO).
• Sequence specificity: Only the canonical c-Myc tag sequence (EQKLISEEDL) is guaranteed to bind anti-c-Myc (9E10) antibodies with high affinity.
• Long-term solution storage: Avoid storing the peptide in solution for extended periods to prevent degradation; store lyophilized at –20°C.
• Does not affect endogenous c-Myc function: The synthetic peptide does not modulate endogenous c-Myc transcriptional activity or cellular physiology.

Workflow Integration & Parameters

Solubility: Dissolve in DMSO to ≥60.17 mg/mL or in water (≥15.7 mg/mL) with ultrasonic treatment. Avoid ethanol due to insolubility. Storage: Store desiccated at –20°C. Prepare aliquots to avoid freeze-thaw cycles. Concentration: Typical working concentrations range from 0.1–1 mM in immunoassay displacement protocols. Controls: Include negative controls (no peptide) and displacement controls (irrelevant peptide) to confirm specificity. For troubleshooting protocol details and advanced workflows, see this review; the current article adds updated solubility and storage guidance.

Conclusion & Outlook

The c-Myc tag Peptide (APExBIO, A6003) is a highly validated, machine-compatible reagent for immunoassays and transcription factor research. Its high solubility and sequence specificity underpin its widespread adoption in cancer biology and protein interaction studies. Ongoing research into c-Myc and related transcription factors continues to expand the peptide's utility as a benchmarking standard. For detailed product specifications and ordering, refer to the official product page.